In this touchENDOCRINOLOGY interview, Dr Ashu Rastogi (Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India) discusses the first randomized, double-blind, placebo-controlled, parallel-group, multi-centre, phase III study evaluating the efficacy of topical esmolol for diabetic foot ulcer healing. Dr Ashu Rastogi also discusses how these results support physicians in providing optimized care for people with diabetic foot ulcers.
The abstract entitled: ‘Novel topical esmolol hydrochloride for diabetic foot ulcer: phase 3, randomised, double-blind, placebo-controlled, multi-centre study’ was presented at the European Association for the Study of Diabetes, 19-23 Sept, 2022.
- What were your findings for topical esmolol in the treatment of diabetic foot ulcers, both versus, and in addition to, standard of care? (0:25)
- How can these results support physicians in providing optimized care for people with diabetic foot ulcers? (2:45)
Disclosures: Ashu Rastogi has nothing to disclose in relation to this video interview.
Support: Interview supported by Touch Medical Media. Interview conducted by Shanice Allen.
Recorded as a highlight of EASD 2022
Share this Video
Related Videos In Diabetes
Chantal Mathieu: Research highlights from 2022
We were delighted to speak with our editorial board member Prof. Chantal Mathieu (University Hospital Gasthuisberg Leuven, Leuven, Belgium) around this year’s research highlights in diabetes and what to look out for in 2023. Questions What are the key clinical highlights from 2022 in the field of diabetes? (0:16) What are the hot topics and […]
José García-Tirado, DTM 2022: RocketAP in Practice: Results from Pilot and Feasibility Trials
In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be. The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility […]
José García-Tirado, DTM 2022: Challenges in the development of artificial pancreas systems
An artificial pancreas is a system made of three parts that work together to mimic how a healthy pancreas controls blood glucose in the body. In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) discusses the major challenges in the development of artificial pancreas systems. The abstract entitled: ‘RocketAP in Practice: Results from Pilot […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!